{
    "question": "In adults with cancer, does adjunctive use of nonsteroidal anti-inflammatory drugs improve overall survival or progression-free survival compared with standard care without NSAIDs? Answer with Yes or No.",
    "content": {
        "source_1": "RESULTS Regular use of aspirin and/or NSAIDs was associated with lower risk of colorectal cancer (prevalence, 28% vs 38%; odds ratio [OR], 0.69 [95% CI, 0.64-0.74]; P = 6.2 Ã— 10(-28)) compared with nonregular use.",
        "source_2": "In genotype-stratified analyses, carriers of the rs2965667-TT variant who reported regular aspirin and/or NSAID use had a higher prevalence of colorectal cancer (38% vs 28%; OR, 1.52 [95% CI, 1.35-1.71]; P < .001), whereas the rare TA or AA genotypes showed no meaningful association with use (OR, 1.05 [95% CI, 0.78-1.41]; P = .72).",
        "source_3": "After multivariable adjustment, regular NSAID use did not reduce colorectal cancer risk in rs16973225-AA carriers (prevalence, 36% vs 39%; OR, 0.97 [95% CI, 0.78-1.20]; P = .76) and was associated with higher risk among those with AC or CC genotypes (prevalence, 35% vs 29%; OR, 1.41 [95% CI, 1.09-1.83]; P = .01)."
    },
    "answer": "No",
    "accuracy_labels": [
        true,
        false,
        false
    ]
}